HER2 gene amplification and/or protein overexpression have been discovered in some cancers in the female genital tract, such as uterine serous carcinoma and ovarian mucinous carcinoma [24, 25]. The gene discussed is ERBB2; the disease is ovarian mucinous adenocarcinoma.